Diversity

FDA issues final rule on clinical trials diversity

30 सितंबर 2025 AI द्वारा रिपोर्ट किया गया

The U.S. Food and Drug Administration has finalized a rule requiring drug sponsors to submit diversity action plans for clinical trials. This aims to ensure better representation of underrepresented groups in medical research. The rule takes effect in 2025.